{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:45Z","timestamp":1791357285189,"version":"4.3.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ogc.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T18:25:03Z","timestamp":1533579903000},"page":"403-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Treatment of Peripartum Bipolar Disorder"],"prefix":"10.1016","volume":"45","author":[{"given":"Crystal T.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Wisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ogc.2018.05.002_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 15","key":"10.1016\/j.ogc.2018.05.002_bib2","first-page":"5","article-title":"Issues in the treatment of women with bipolar illness","volume":"58","author":"Leibenluft","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.ogc.2018.05.002_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/GRF.0b013e3181b5a57c","article-title":"Identification of postpartum depression","volume":"52","author":"Sit","year":"2009","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2018.05.002_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1192\/bjp.172.6.521","article-title":"Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition","volume":"172","author":"Terp","year":"1998","journal-title":"Br J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2018.05.002_bib5","first-page":"1","article-title":"Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2018.05.002_bib6","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2015.18948","article-title":"Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force","volume":"315","author":"O\u2019Connor","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ogc.2018.05.002_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2013.87","article-title":"Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings","volume":"70","author":"Wisner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ogc.2018.05.002_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale","volume":"150","author":"Cox","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10.1016\/j.ogc.2018.05.002_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J\u00a0Gen Intern Med"},{"issue":"11","key":"10.1016\/j.ogc.2018.05.002_bib11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00737-015-0527-y","article-title":"Screening for bipolar disorder during pregnancy","volume":"18","author":"Merrill","year":"2015","journal-title":"Arch Womens Ment Health"},{"issue":"7","key":"10.1016\/j.ogc.2018.05.002_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/da.22373","article-title":"Does screening with the MDQ and EPDS improve identification of bipolar disorder in an obstetrical sample?","volume":"32","author":"Clark","year":"2015","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.162.1.79","article-title":"Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders","volume":"162","author":"Jablensky","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.ogc.2018.05.002_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09540261.2010.514600","article-title":"Childbirth and mental disorders","volume":"22","author":"Leight","year":"2010","journal-title":"Int Rev Psychiatry"},{"issue":"12","key":"10.1016\/j.ogc.2018.05.002_bib16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.ogc.2018.05.002_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.2012.11071047","article-title":"Prevention of postpartum psychosis and mania in women at high risk","volume":"169","author":"Bergink","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","article-title":"A\u00a0reevaluation of risk of in utero exposure to lithium","volume":"271","author":"Cohen","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/HCO.0000000000000124","article-title":"When should we prescribe high-dose folic acid to prevent congenital heart defects?","volume":"30","author":"Huhta","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"7","key":"10.1016\/j.ogc.2018.05.002_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1176\/appi.ajp.2014.12111402","article-title":"Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study","volume":"171","author":"Diav-Citrin","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijoa.2007.09.014","article-title":"Lithium toxicity and the parturient: case report and literature review","volume":"17","author":"Blake","year":"2008","journal-title":"Int J Obstet Anesth"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ajmg.a.30501","article-title":"Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: another clinical report and a review of the literature","volume":"132A","author":"Kozma","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.ogc.2018.05.002_bib23","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy","volume":"162","author":"Newport","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.ogc.2018.05.002_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.earlhumdev.2011.09.013","article-title":"Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies","volume":"88","author":"van der Lugt","year":"2012","journal-title":"Early Hum Dev"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","article-title":"Management of bipolar disorder during pregnancy and the postpartum period","volume":"161","author":"Yonkers","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"Deligiannidis","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"5859","key":"10.1016\/j.ogc.2018.05.002_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.2.5859.137","article-title":"Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery","volume":"2","author":"Schou","year":"1973","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/bjp.bp.116.192799","article-title":"Lithium dosing strategies during pregnancy and the postpartum period","volume":"211","author":"Wesseloo","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-3476(72)80111-2","article-title":"Toxic effects of lithium in newborn infants: a commentary","volume":"81","author":"Tunnessen","year":"1972","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.ogc.2018.05.002_bib30","first-page":"400","article-title":"Breast feeding during lithium therapy","volume":"139","author":"Skausig","year":"1977","journal-title":"Ugeskr laeger"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/ajp.2007.164.2.342","article-title":"Lithium in breast milk and nursing infants: clinical implications","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ogc.2018.05.002_bib32","unstructured":"LactMed. Lithium. Available at: http:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/search2\/r?dbs+lactmed:@term+@DOCNO+293. Accessed June 18, 2018."},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00737-012-0257-3","article-title":"Three cases of lithium exposure and exclusive breastfeeding","volume":"15","author":"Bogen","year":"2012","journal-title":"Arch Womens Ment Health"},{"issue":"21","key":"10.1016\/j.ogc.2018.05.002_bib34","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ogc.2018.05.002_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"21","key":"10.1016\/j.ogc.2018.05.002_bib36","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/WNL.0b013e31821ccd18","article-title":"Final results from 18 years of\u00a0the International Lamotrigine Pregnancy Registry","volume":"76","author":"Cunnington","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ogc.2018.05.002_bib37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ogc.2018.05.002_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"22 Pt 2","key":"10.1016\/j.ogc.2018.05.002_bib39","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.ogc.2018.05.002_bib40","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0000000000002540","article-title":"Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies","volume":"86","author":"Dolk","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ogc.2018.05.002_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis","volume":"31","author":"Pariente","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ogc.2018.05.002_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.reprotox.2013.06.001","article-title":"Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function","volume":"41","author":"Rihtman","year":"2013","journal-title":"Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/01.WNL.0000103286.47129.F8","article-title":"The impact of pregnancy and childbirth on the metabolism of lamotrigine","volume":"62","author":"Pennell","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ogc.2018.05.002_bib45","unstructured":"GlaxoSmithKline. Lamictal Medication Guide. 2016."},{"key":"10.1016\/j.ogc.2018.05.002_bib46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder","volume":"61","author":"Clabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.ogc.2018.05.002_bib47","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1176\/appi.ajp.2013.13010006","article-title":"Lamotrigine dosing for pregnant patients with bipolar disorder","volume":"170","author":"Clark","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1600-0404.2011.01627.x","article-title":"Algorithm for lamotrigine dose adjustment before, during, and after pregnancy","volume":"126","author":"Sabers","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"22 Part 2","key":"10.1016\/j.ogc.2018.05.002_bib49","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","article-title":"Developmental aspects of human hepatic drug glucuronidation in young children and adults","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ogc.2018.05.002_bib51","unstructured":"LactMed. Lamotrigine. Available at: http:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/search2\/r?dbs+lactmed:@term+@DOCNO+399. Accessed June 18, 2018."},{"issue":"11","key":"10.1016\/j.ogc.2018.05.002_bib52","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1345\/aph.1M254","article-title":"Severe apnea in an infant exposed to lamotrigine in breast milk","volume":"43","author":"Nordmo","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.ogc.2018.05.002_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.57.2.321","article-title":"Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies","volume":"57","author":"Diav-Citrin","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","article-title":"The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures","volume":"16","author":"Matalon","year":"2002","journal-title":"Reprod Toxicol"},{"issue":"7","key":"10.1016\/j.ogc.2018.05.002_bib56","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1528-1157.2000.tb00253.x","article-title":"Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years","volume":"41","author":"Wide","year":"2000","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ogc.2018.05.002_bib57","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","article-title":"Population-based study of antiepileptic drug exposure in utero\u2013influence on head circumference in newborns","volume":"18","author":"Almgren","year":"2009","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00239754","article-title":"Anticonvulsant drugs in monotherapy. Effect on the fetus","volume":"3","author":"Bertollini","year":"1987","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF02072057","article-title":"Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding","volume":"150","author":"Frey","year":"1990","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.ogc.2018.05.002_bib60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867417726175","article-title":"Mood stabilizers in pregnancy and child developmental outcomes: a systematic review","volume":"51","author":"Haskey","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","article-title":"Normal intelligence in children with prenatal exposure to carbamazepine","volume":"62","author":"Gaily","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ogc.2018.05.002_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2014.02.011","article-title":"Carbamazepine clearance and seizure stability during pregnancy","volume":"33","author":"Johnson","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1345\/aph.1A326","article-title":"Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding","volume":"36","author":"Frey","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ogc.2018.05.002_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"The transfer of drugs and other chemicals into human milk","volume":"108","author":"Ward","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":"Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries","volume":"16","author":"Toh","year":"2013","journal-title":"Arch Womens Ment Health"},{"issue":"9","key":"10.1016\/j.ogc.2018.05.002_bib66","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.ogc.2018.05.002_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","article-title":"Reproductive safety of second-generation antipsychotics: current data from the massachusetts general hospital national pregnancy registry for atypical antipsychotics","volume":"173","author":"Cohen","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.ogc.2018.05.002_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.109.076935","article-title":"Treatment with antipsychotics and the risk of diabetes in clinical practice","volume":"197","author":"Kessing","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib71","doi-asserted-by":"crossref","first-page":"416.e1-6","DOI":"10.1016\/j.ajog.2007.10.796","article-title":"Impact of maternal body mass index on neonate birthweight and body composition","volume":"198","author":"Hull","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2018.05.002_bib72","unstructured":"National Pregnant Registry for atypical antipshychotics 2016. Available at: https:\/\/womensmentalhealth.org\/clinical-and-research-programs\/pregnancyregistry\/atypicalantipsychotic\/. Accessed June 18, 2018."},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","article-title":"Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study","volume":"228","author":"Peng","year":"2013","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib74","doi-asserted-by":"crossref","first-page":"e0123373","DOI":"10.1371\/journal.pone.0123373","article-title":"Effects of clozapine and other atypical antipsychotics on infants development who were exposed to as fetus: a post-hoc analysis","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ogc.2018.05.002_bib75","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000491","article-title":"Second-generation antipsychotics during the lactation period: a comparative systematic review on infant safety","volume":"36","author":"Uguz","year":"2016","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ogc.2018.05.002_bib76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy","volume":"192","author":"Tracy","year":"2005","journal-title":"Am J obstetrics Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ogc.2018.05.002_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12888-016-1092-2","article-title":"Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial","volume":"16","author":"Bais","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.2017.16101200","article-title":"Adjunctive bright light therapy for bipolar depression: a randomized double-blind placebo-controlled trial","volume":"175","author":"Sit","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.ogc.2018.05.002_bib81","first-page":"113","article-title":"The efficacy of electroconvulsive therapy in a perinatal population: a comparative pilot study","volume":"32","author":"Haxton","year":"2016","journal-title":"J\u00a0ECT"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T18:54:51Z","timestamp":1533581691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854518300482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0889854518300482"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2018.05.002","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Peripartum Bipolar Disorder","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}